Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02918383 · ClinicalTrials.gov registry record · NA
Subchondral Perfusion Mapping Using Indocyanin Green Laser
A NA study, sponsored by Loma Linda University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02918383 is a NA study that was terminated before completion, run by Loma Linda University. The registered enrollment target is 2 participants.
The verdict
NCT02918383, a NA study, was terminated before completion, sponsored by Loma Linda University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Laser Angiography using indocyanin green (ICG) is a relatively new technique and has been utilized to assess the viability of soft tissue, most prominently in the general surgery and plastic surgery literature. This technique has been used for prediction of soft tissue viability by assessing the perfusion status. There is currently no Orthopaedic literature regarding the use of this device for assessment of subchondral perfusion of articular surfaces such as the distal femur or other chondral surfaces. In this pilot study, the use of ICG to detect the perfusion status of a distal femur and proximal tibia during a surgical approach to the knee and correlating this to visible signs of arthritis. For example, due to the difference visible with ICG angiography correlate to gross changes in the cartilage health visible to the naked eye with radiographic imaging.
Interventions
- DIAGNOSTIC_TEST Indocyanin Green Dye (ICG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2016-06 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02918383
The ClinicalTrials.gov registry entry for NCT02918383 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Indocyanin Green Dye (ICG) is the first listed.
NCT02918383 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02918383 about?
NCT02918383 is a clinical study titled "Subchondral Perfusion Mapping Using Indocyanin Green Laser". Laser Angiography using indocyanin green (ICG) is a relatively new technique and has been utilized to assess the viability of soft tissue, most prominently in the general surgery and plastic surgery literature. This technique has been used for prediction of soft tissue viability by assessing the per...
What is the current status of trial NCT02918383?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2016-06. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02918383?
The interventions under investigation include: Indocyanin Green Dye (ICG) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02918383?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.